Vergoeding 2016-2020 voor ATC-subgroep A16AX : Diverse maagdarmkanaal- en metabolismeproducten
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| A16AX03 Fenylboterzuur (Ammonaps ®) | 321.320 | 419.950 | 388.800 | 217.730 | 202.140 |
| A16AX04 Nitisinon (Orfadin ®) | 2.003.600 | 2.029.600 | 2.317.700 | 2.200.300 | 2.053.000 |
| A16AX05 Zinkacetaat (Wilzin ®) | 65.779 | 53.914 | 70.205 | 78.527 | 76.888 |
| A16AX06 Miglustat (Zavesca ®) | 1.422.300 | 1.424.500 | 1.627.900 | 1.597.900 | 1.480.300 |
| A16AX07 Sapropterine (Kuvan ®) | 5.445.100 | 6.358.100 | 6.342.700 | 6.722.300 | 6.575.300 |
| A16AX09 Glycerolfenylbutyraat (Ravicti ®) | . | . | 96.581 | 442.570 | 584.390 |
| A16AX10 Eliglustat (Cerdelga ®) | . | 670.000 | 2.461.000 | 2.167.400 | 2.204.000 |
| A16AX11 Benzoaat natrium | 35.774 | 49.952 | 56.370 | 68.574 | 79.710 |
| A16AX12 Trientine (Cuprior ®) | . | . | . | . | 490.330 |
| A16AX15 Telotristat (Xermelo ®) | . | . | 28.596 | 227.560 | 310.920 |
| Totaal | 9.293.873 | 11.006.016 | 13.389.852 | 13.722.861 | 14.056.978 |